MSK conditions are common and costly
Did you know that:
- 50% of adult Americans live with a musculoskeletal condition.
- 75% of MSK surgeries are avoidable with non-operative care.1
- Direct medical expenditures per year are over $213 billion in treatment, care and lost wages annually.2
Integrated capabilities
Utilization management
We support delivery of high-quality, evidence-based care through strong relationships with treating providers.
Network access
Top facilities and physical health providers help ensure quality care and convenient access at negotiated rates.
Digital tools
Our multi-modal solution consists of physical exercises, education and access to physical therapists.
Key benefits
Provide member and employee support and access to high-value sites of care while driving quality outcomes and financial savings.
35% savings
Our members spend less with help from utilization management and our national outpatient rehab network.1
28% savings
Our members can save on procedures performed at a surgical COE.2
3:1 ROI
Over several years our members have shown to have an overall favorable ROI.3
An integrated approach to MSK care
Our integrated approach supports members across the care continuum, ensuring care is provided at the right place and the right time.
- Digital tools enable members to stay on track with self-directed care.
- High-quality care providers and surgical center access may help improve outcomes and savings.
- Payment integrity capabilities can help to reduce overutilization of services and inappropriate billing practices.
- Provider collaboration capabilities foster alignment on medically appropriate care.
Industry insights
Article
Musculoskeletal surgeries are driving up costs. Payers can bend the curve with digital care, expert second opinions and high-performing surgical centers.
Article
Virtual second opinions give members a checkpoint before major treatment decisions. Labor and trust funds get better outcomes and smarter spend.
White paper
This white paper analyzes CAR T utilization, outcomes and economic impact across commercial and Medicare populations in the Optum Cell and Gene Therapy (CGT) program from 2022–2024.
Product information and resources
-
Download fact sheet
PDF
Fact sheet
About Musculoskeletal Solutions
See how Optum Musculoskeletal Solutions can help reduce the prevalence of MSK injuries while driving an overall 3:1 ROI.3
- Hinge Health State of MSK 2022
- boneandjointburden.org. Accessed March 2023.
- Optum proposed and book of business, 2022. Stats determined from aggregated data over several years, single year results may vary, and results may not be typical.